Status:
COMPLETED
ESP in Breast Surgery Due to Cancer
Lead Sponsor:
Medical University of Lublin
Conditions:
Breast Cancer
Pain, Acute
Eligibility:
FEMALE
18-80 years
Phase:
PHASE4
Brief Summary
Patients scheduled for breast surgery due to cancer. Each patient will be treated with intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be allocated to one of three gro...
Detailed Description
Only patients who are qualified for an elective procedure of mitral breast surgery may participate in the study. Each patient will be anesthetized generally. The same drugs will be used in each stage ...
Eligibility Criteria
Inclusion
- Elective surgery of breast due to cancer
- obtained consent
Exclusion
- the lack of consent
- the surgery of two breasts
- reoperation of the same breast
- previous participation in the study
- coagulopathy
- allergy to morphine and local anesthetics
- depression, antidepressant drugs treatment
- epilepsy
- usage of painkiller before surgery
- addiction to alcohol or recreational drugs
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04726878
Start Date
February 1 2021
End Date
August 17 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
II Department of Anesthesia and Intensive Care, Medical University of Lublin
Lublin, Poland, 20-081